A talk at the launch of a new book on Intellectual Property Valuation and Innovation. Second chapter sourced from Future Agenda discussions and perspectives looks at severn potential changes for the innovation and intellectual property landscape over the next decade. Launch taking place on 28 Nov 2013 at Kingston Smith LLP London
2. Innova-on
and
Intellectual
Property
Innova6on
is
increasingly
moving
beyond
the
established
arenas
of
product
and
technology
development
where
IP
has
tradi6onally
had
a
major
role
to
play
-‐
we
need
to
understand
poten6al
future
impact.
3. Looking
Forwards
Organisa6ons
increasingly
want
to
iden6fy
and
understand
both
the
an6cipated
and
unexpected
changes
from
within
and
outside
their
sector
so
that
they
can
be
beHer
prepared
for
the
future
4. Looking
Back
Ten
years
ago
some
saw
the
emerging
shiIs
that
might
have
impact
to
include
the
resurgence
of
patent
pools,
IP
development
companies
and
new
financial
strategies
such
as
Asset
Backed
Securi6za6on
5. #
US
Patents
Granted
(USPTO)
1400
1200
1000
800
Amazon
600
Google
400
200
0
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
Companies
of
Note
Over
the
past
decade
many
have
been
surprised
by
shiIs
such
as
the
success
of
ARM’s
licensing
business
model
and
the
ways
in
which
Amazon
and
Google
have
built
and
exploited
their
IP
porUolios
6. Future
Agenda
The
Future
Agenda
is
the
world’s
largest
open
foresight
programme
that
engages
expert
input
from
over
1500
organisa6ons
to
beHer
understand
the
next
decade
7. 1.
2.
3.
4.
5.
6.
7.
Differen6ated
Knowledge
The
End
of
IP
Failed
Drugs
Business
Model
Open
Innova6on
Corporate
LEGO
Projects
Worth
Working
For
Big
Collabora6on
We
see
seven
issues
that
may
have
significant
future
impact
8. Differen-ated
Knowledge
As
informa6on
is
shared
globally
and
insight
is
commodi6zed,
the
best
returns
go
to
those
who
can
produce
non-‐standard,
differen6ated
knowledge.
9. The
End
of
IP
Following
change
in
the
music
industry,
technologies
such
as
3D
prin6ng
are
decoupling
the
produc6on
of
content
from
the
original
creator
and,
in
doing
so,
IP
is
becoming
irrelevant.
10. Failed
Drugs
With
pressure
on
‘big
pharma’
to
deliver
more
effec6ve
R&D,
the
IP
associated
with
drugs
that
fail
in
clinical
trials
is
being
more
openly
shared
for
others
to
find
beneficial
applica6ons.
11. Business
Model
Open
Innova-on
Increasing
sector-‐to-‐sector
transfer
of
know-‐how
independent
of
IP
enables
successful
approaches
to
be
adopted
and
adapted
without
value
transfer
between
par6es.
12. Corporate
LEGO
With
more
free
agents
and
outsourcing,
more
func6ons
within
organiza6ons
are
interchangeable
and
easily
rebuilt
around
new
value-‐crea6ng
units.
13. Projects
Worth
Working
For
In
a
world
where
innova6on
talent
is
global,
fluid
and
aHracted
by
the
challenge
or
reputa6on
more
than
the
paycheck,
the
winners
will
be
the
organiza6ons
that
provide
the
most
interes6ng
projects.
14. Big
Collabora-on
Addressing
future
major
challenges
relies
on
deeper
and
wider
collabora6on
between
organiza6ons
with
no
lead
company
and
IP
value
crea6on
replaced
by
new
recogni6on.
15. Intellectual
Property
Valua-on
and
Innova-on
Edited
by
Ruth
Taplin
Hardcover:
208
pages
Publisher:
Routledge
(21
Oct
2013)
ISBN-‐10:
0415532159
ISBN-‐13:
978-‐0415532150
hHp://www.amazon.co.uk/dp/0415532159
More
Informa-on
For
more
details
on
these
thoughts
please
see
the
futureagenda
website
and
the
second
chapter
in
“Intellectual
Property
Valua6on
and
Innova6on”
recently
published
by
Routledge.
16. The
world’s
leading
open
foresight
program
Future
Agenda
84
Brook
Street
London
W1K
5EH
+44
203
0088
141
futureagenda.org
6m.jones@futureagenda.org